SCHEMBL24467137

SCHEMBL24467137

CCN1C[C@H]2CC[C@@H](C1)N2C(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7839598 1.00 ATM (0.30) ATML3MBTL1
SCHEMBL20071254 0.86
SCHEMBL22308994 0.80 PIK3CD (0.50)
SCHEMBL12885044 0.79 GLB1 (0.46)
SCHEMBL26147477 0.78 GBA1 (0.32)
SCHEMBL8374381 0.78 LMNA (0.39) ATML3MBTL1
SCHEMBL26511415 0.77 PIK3CD (0.34)
SCHEMBL7859505 0.77 GBA1 (0.34)
SCHEMBL19298588 0.75
SCHEMBL27306236 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3534899-B1 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS INC (US) 2022-06-01 EP disclosed